NAPANEE, ON , June 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has made a $1.25 million strategic investment in Friendly...
NAPANEE, ON , June 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has made a $1.25 million strategic investment in Friendly...
VIVO Completes First Canadian Installation of Innovative Airhouses in Napanee
NAPANEE, ON , June 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has received...
NAPANEE, ON , June 5, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use...
NAPANEE, ON , May 29, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use...
NAPANEE, ON , May 22, 2019 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has signed a distribution agreement with Burleigh Heads Cannabis...
Vivo Cannabis™ to report Q1 2019 results on May 29, 2019
VIVO Adds New Craft Producer GTEC Holdings Inc. and Additional Pure Sun Farms Products to On-Line Medical C
VIVO Adds New Craft Producer GTEC Holdings Inc. and Additional Pure Sun Farms Products to On-Line Medical Cannabis Platform
HOPE, BC , May 10, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company") is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"),...
NAPANEE, ON , April 30, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use...
The expansion consists of 10,000 square feet of cultivation space, with expected capital costs of $3.5 million and is expected to bring VIVO's total internal production capacity to 13,500 kilograms by...
ABcann's group of companies will be the first to produce repeatable, standardized, plant-based medicines worldwide.
ABcann will produce products with integrity in a customer focused culture where social responsibility and environmental impacts are mandated.